Seer, Inc. (NASDAQ:SEER – Get Rating) COO Omead Ostadan sold 4,441 shares of the company’s stock in a transaction dated Friday, May 27th. The stock was sold at an average price of $8.06, for a total transaction of $35,794.46. Following the sale, the chief operating officer now directly owns 378,238 shares of the company’s stock, […]
Seer (NASDAQ:SEER – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. […]
REDWOOD CITY, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for.